Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

被引：0
|
作者：
Xiao-yan Qiu
Zheng Jiao
Ming Zhang
Long-jin Zhong
Hui-qi Liang
Chun-lai Ma
Liang Zhang
Ming-kang Zhong
机构：
[1] Fudan University,Clinical Pharmacy Laboratory, Huashan Hospital
[2] Fudan University,School of Pharmacy
[3] Fudan University,Department of Nephrology, Huashan Hospital
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
MDR1; CYP3A4*18B; CYP3A5*3; Cyclosporine; Renal transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association Between CYP3A5☆1 and CYP3A5☆3 Polymorphisms, With the Formation of ADES and the Presence of Rejection in Renal Transplant Recipients
    Garcia, Luis
    Quintanilla, Alan
    Hinojosa, Hector
    Vargas, Lionel
    Fernandez, Diana
    Garcia, Aldo
    TRANSPLANTATION, 2022, 106 (09) : S275 - S275
  • [32] Influence of Cyp3a4, Cyp3a5 and Mdr1-C3435t Genetic Polymorphisms in Tacrolimus Pharmacokinetics in Adult Renal Transplant Patients
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Seoane-Pillado, M. T.
    Pedreira-Vazquez, I
    Martin-Herranz, I
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 657 - 658
  • [33] CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients
    Li, Dan-ying
    Teng, Rui-chen
    Zhu, Huai-jun
    Fang, Yun
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (06) : 466 - 474
  • [34] Influence of CYP3A4*1B and CYP3A5*1 polymorphisms on tacrolimus exposure in Tunisian kidney transplant recipients
    Ben Fredj, N.
    Kerkni, E.
    Baptiste, W. Jean
    Chaabane, A.
    Hammouda, M.
    Kolsi, A.
    Skhiri, H.
    Boughattas, N.
    Aouam, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 62 - 62
  • [35] Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients
    Li, Jia-li
    Liu, Shu
    Fu, Qian
    Zhang, Yu
    Wang, Xue-ding
    Liu, Xiao-man
    Liu, Long-shan
    Wang, Chang-xi
    Huang, Min
    PHARMACOGENOMICS, 2015, 16 (12) : 1355 - 1365
  • [36] Effect of CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Sirolimus in Healthy Chinese Volunteers
    Zhang, Jing
    Dai, Ying
    Liu, Zhihong
    Zhang, Minxin
    Li, Chen
    Chen, Dingxiong
    Song, Hongtao
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 406 - 411
  • [37] CYP3A5 and MDR1 polymorphisms in pediatric kidney transplant recipients receiving calcineurin inhibitors
    Tirelli, Amedea Silvia
    Ghio, Luciana
    Ferraresso, Mariano
    Belingheri, Mirco
    Berardinelli, Luisa
    Turolo, Stefano
    Torresani, Erminio
    Edefonti, Alberto
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 544 - 544
  • [38] Cyclosporine steady-state pharmacokineties in heart transplant patients in relation to MDR1, CYP3A4 and CYP3A5 genotypes -: Preliminary observation
    Kunicki, Pawel K.
    Sobieszczanska-Malek, Malgorzata
    Piotrowska, Malgorzata
    Gornik, Wanda
    Drozdzik, Marek
    Adler, Grazyna
    Ciechanowicz, Andrzej
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 544 - 545
  • [39] Impact of CYP3A5 and MDR1 polymorphisms on tacrolimus and sirolimus kinetics of kidney transplant recipients
    Frisman, M
    Renders, L
    Haenisch, S
    Mosyagin, I
    Cascorbi, I
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 705 - 706
  • [40] Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CMC19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients
    Miura, Masatomo
    Inoue, Kazuyuki
    Kagaya, Hideaki
    Satoh, Shigeru
    Tada, Hitoshi
    Sagae, Yoshinori
    Habuchi, Tomonori
    Suzuki, Toshio
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (04) : 167 - 175
12345